ArticleJournal of neurosurgery. Case lessons2025
Can posterior fossa decompression alone effectively treat Chiari malformation type I patients with even severe syringes? Illustrative cases.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe benefit of posterior fossa decompression (PFD) alone (without duraplasty) for Chiari malformation type I (CM-I) remains controversial. Many neurosurgeons still open the dura when a syrinx is present, particularly for what appears to be a severe syrinx. Based on the existing literature, the authors hypothesized that even a severe syrinx would respond well to a PFD alone. OBSERVATIONS: In a proof-of-principle study, the authors prospectively included 4 patients with CM-I, aged 3-15 years, with severe symptomatic syringes (spanning multiple cervical/thoracic levels and/or focally expanding the spinal cord) to undergo PFD with pre- and postdissection intraoperative MRI (iMRI). In all cases, same-day postdissection iMRI cine images showed enhanced CSF flow compared with predissection iMRI findings. Three of the 4 patients showed early syrinx and symptom improvement (≤ 6 weeks); all showed improvements at long-term follow-up (≥ 2 years). The mean hospital length of stay (LOS) was 1.25 days, with no complications or repeat surgery needed, and the mean follow-up was 37.5 months. LESSONS: CM-I can be treated via PFD alone without duraplasty, even with a severe syrinx. Improved CSF flow is achieved intraoperatively, and the syrinx can significantly decrease over a 6-week to 1-year period postoperatively. Additional benefits include a low risk of complications and a short LOS. https://thejns.org/doi/10.3171/CASE24777.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.